Apexigen, Inc. Temporary Equity, Accretion to Redemption Value
Apexigen, Inc. reported Temporary Equity, Accretion to Redemption Value of $5.70 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-04-07.
Discontinued › Shareholders' Equity
us-gaap:TemporaryEquityAccretionToRedemptionValue · last filed 2022-08-18
- Apexigen, Inc. temporary equity, accretion to redemption value for the quarter ending 2021-03-31 was $5.70M.
- Apexigen, Inc. temporary equity, accretion to redemption value for fiscal 2021 was $5.70M.
| Period end | Temporary Equity, Accretion to Redemption Value 3 month | Temporary Equity, Accretion to Redemption Value 3 month as first filed | Temporary Equity, Accretion to Redemption Value 12 month |
|---|---|---|---|
| 2021-12-31 | $5.70M 10-K · filed 2022-04-07 | ||
| 2021-03-31 | $5.70M 10-Q · filed 2022-08-18 | $1.85M 10-Q · filed 2021-12-09 |